Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework

Development of effective counteragents against the novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains, requires clear insights and information for understanding the immune responses associated with it. This global pandemic has pushed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Neeraj, Admane, Nikita, Kumari, Anchala, Sood, Damini, Grover, Sonam, Prajapati, Vijay Kumar, Chandra, Ramesh, Grover, Abhinav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027208/
https://www.ncbi.nlm.nih.gov/pubmed/33828130
http://dx.doi.org/10.1038/s41598-021-86986-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027208/
https://www.ncbi.nlm.nih.gov/pubmed/33828130
http://dx.doi.org/10.1038/s41598-021-86986-6

Ejemplares similares